Intracranial Stents Market

  • The global intracranial stents market value is expected to reach USD 695.7 million by 2026 growing at a CAGR of 9.50%.
  • An intracranial stent is a tubular structure that is placed inside the canal, duct, or blood vessel. They are used for the treatment of intracranial stenosis.
  • Intracranial stenosis is caused by narrowing of the blood vessels or blood clots due to building up of fats, plaque, and other substances in the blood vessels. This condition causes stroke in the carotid artery in the neck or an intracranial artery.
  • A stroke is a brain attack that occurs by a lack of or reduced blood supply to a part of the brain. Stents act as a permanent implant that provides relief from obstruction and allows continuous flow of the fluid.
  • Prevalence of intracranial atherosclerotic disease is highly prevalent in African, Asian, Hispanic Americans, and Latino American population.
  • According to World Health Organization (WHO), in U.S. stroke was the third leading cause of death in 2018, over 140,000 people die by stroke annually, 1 out of 6 people over the world has a stroke in their lifetime.
  • About 15 million people suffer from a stroke annually, and approximately 5.8 million people die from it. Intracranial atherosclerosis contributes to about 8-10% of total strokes.


Intracranial Stents Market Drivers

  • The significant drivers driving the market are a rapid rise in the geriatric population, increase in the incidence of chronic neurological diseases like brain aneurysm and hypertension, cholesterol, and diabetes and technical advances in the field of self-expanding stents and improvement in flexibility of the stents.
  • According to the Brain Aneurysm Foundation (BAF), brain aneurysm causes around 500,000 deaths worldwide annually and is more common among women.
  • BAF estimates that aneurysm is predominant in the age group of 35–60 years and its occurrence increase if a first-degree relative like a parent, sibling, or child has aneurysms. Patients with genetic disorders like connective tissue disorders or polycystic kidney disease usually suffer from cerebral aneurysms.
  • Additionally, stroke is more prevalent among the geriatric population, according to the United Nations, Department of Economic and Social Affairs, Population Division, between 2012 and 2017, the global community aged 65 and above increased by 68% in urban areas and by 25% in the rural areas and around 75-89% of strokes occur in individuals aged > 65 years. Of these strokes, 50% occur in people who are aged ≥ 70 years, and nearly 25% occur in individuals who are aged > 85 years. As per the United Nation’s data, it is estimated that the aging population will rise from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100, globally.


Intracranial Stents Market Restraints

  • Tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers and fewer acceptances among surgeons due to the risks of complications regarding the stent movement and bleeding in the brain after surgery are going to restrain the market in the forecast period.


Intracranial Stents Market Segmentation Analysis

  • The global intracranial stents market is segmented based on product type as self-expanding stents, balloon expanding stents and stent-assisted coil embolization, by disease indication as intracranial stenosis and brain aneurysm, by design as open-cell and closed-cell, by uses as Neuroform, Solitaire, Enterprise, Leo Plus, and Wingspan, by end-user and by region.
  • Wingspan is widely used for the treatment of intracranial atherosclerotic diseases; whereas, Neuroform, Solitaire, Enterprise, and Leo Plus assist in coiling. The stent-assisted coiling is widely used as stenosis treatment and dominates the market.
  • According to the American Journal of Neuroradiology, around 37% of stenosis treatments uses stent-assisted coiling as it is a minimally invasive procedure that offers a non-surgical option to patients with wide neck aneurysms. It comprises placing a stent inside a wide neck aneurysm and protects blood vessel walls from getting damaged.


Intracranial Stents Market Geographical Share

  • Geographically, the global intracranial stents market is divided into North America, Europe, South America, Asia-Pacific and rest of the world.
  • High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare makes North America largest revenue generator in the market. According to the Centers for Disease Control and Prevention (CDC), neurological disorders such as epilepsy, Alzheimer’s, strokes, multiple sclerosis, and migraines are the 5th leading cause of death in the U.S., affecting around 100 million people every year. This large patient pool costs the nation 800 billion annually, including the cost of health care services, medications, and lost productivity.
  • This large volume of patients with stroke requires intracranial stenting. As per the American Heart Association, in the year 2018, atherosclerotic stenosis was identified as the primary cause of around 700,000 strokes.


Intracranial Stents Market Competitive Analysis

  • Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc., Terumo Corporation, Cook Medical, DePuy Synthes, Balt Extrusion S.A., MicroPort Scientific Corporation and Abbott Laboratories are some of the primary key players.
  • In May 2018, MicroVention, Inc., received USFDA Premarket Approval (PMA) for the Low profile Visualized.
  • Intraluminal Support (LVIS) and LVIS Jr. stents for stent-assisted coil embolization of intracranial aneurysms.
  • In January 2018, Stryker announced the positive results of WEAVE, the post-market surveillance study of the company’s Wingspan stent system, for the patients suffering from the intracranial atherosclerotic disease.
  • In November 2017, Stryker Corporation received the USFDA approval for its Neuroform Atlas Stent System, for marketing under the HDE. The device has been designed to provide the coil support and wall apposition needed to perform effective stent-assisted coiling procedures.
  • In January 2017, MicroPort Medical (Group) Co., Ltd. received China Food and Drug Administration (FDA) approval for their portfolio of APOLLO Intracranial Stent System in large sizes, for treating intracranial artery stenosis by improving blood supply in cerebral arteries.


Why purchase the report?

  • Visualize the composition of the intracranial stents market across each indication, in terms of type and by type highlighting the key commercial assets and players.
  • Identify business opportunities in intracranial stents by analyzing trends and co-development deals.
  • Excel data sheets with thousands of data points of intracranial stents market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the principal products of all major market players.


Who can benefit from this report?

  • Medical device companies
  • Hospitals and clinics
  • Research and consulting firms
  • Healthcare associations/institutes
  • Venture capitalists
  • Government agencies

Global Intracranial Stents Market

1. Intracranial Stents Market Scope and Methodology

1.1. Research Methodology

1.2. The scope of the market

2. Intracranial Stents Market Trends

2.1. Key Market Trends and Developments in Intracranial Stents Market

3. Intracranial Stents Market Outlook

3.1. Drivers

3.2. Restraints

3.3. Opportunity

3.4. Pricing Analysis

3.5. Regulation

3.6. Supply Chain Analysis

3.7. Reimbursement Policies

3.8. Technological Advancements

3.9. PEST analysis

3.10. Porter’s Five Forces Analysis

4. Intracranial Stents Market Segmentation Analysis

4.1. By Product Type

4.1.1. Self-expanding stents

4.1.2. Balloon expanding stents

4.1.3. Stent-assisted coil embolization

4.2. By Disease Indication

4.2.1. Intracranial stenosis

4.2.2. Brain aneurysm

4.3. By Design

4.3.1. Open-cell

4.3.2. Closed-cell

4.4. By Uses

4.4.1. Neuroform

4.4.2. Solitaire

4.4.3. Enterprise

4.4.4. Leo Plus

4.4.5. Wingspan

4.5. By End User

4.5.1. Hospitals

4.5.2. Ambulatory Surgical Centers

4.5.3. Clinics

4.5.4. Others

5. Intracranial Stents Market – Regional, Country-level Analysis

5.1. Geographic Overview

5.2. North America

5.2.1. The U.S.

5.2.2. Mexico

5.2.3. Canada

5.3. Europe

5.3.1. Germany

5.3.2. The U.K.

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Rest of Europe

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. Asia Pacific

5.5.1. China

5.5.2. India

5.5.3. Japan

5.5.4. Australia

5.5.5. Rest of Asia Pacific

5.6. Rest of the World

6. Intracranial Stents Market Competitive Analysis

6.1. Competitive Scenario

6.2. Heat Map Analysis

6.3. Product Benchmarking

7. Intracranial Stents Market Company Profiles

7.1. Penumbra, Inc.

7.2. Medtronic plc

7.3. Stryker Corporation

7.4. Boston Scientific Corporation Inc.

7.5. Terumo Corporation

7.6. Cook Medical

7.7. DePuy Synthes

7.8. Balt Extrusion S.A.

7.9. MicroPort Scientific Corporation

7.10. Abbott Laboratories

8. Intracranial Stents Market – Key companies to watch

9. Intracranial Stents Market – Emerging companies

10. Intracranial Stents Market – Appendix

10.1. Sources

10.2. List of Tables

10.3. Expert Panel Validation

10.4. Disclaimer

10.5. Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report